Skip to content

Aliaxin EV - Essential Volume (Direct Countries)

by Rose Pharma S.A.

Ref Aliaxin EV - Essential Volume (Direct Countries)

Active European Union

CE MDR

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 25 Oct 2026. What this means

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number764018792IDCLHAEK Basic UDI-DI 07640187920451UDI-DIDate9 Oct 2026RegisteredStatusActive

Certificates

0 certificates · EUDAMED

EUDAMED lists no certificate for this device's Basic UDI-DI.

A certificate issued for a device group may exist without being linked here.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device Name
Intradermal Cross-Linked Ha
Model / Reference
Aliaxin EV - Essential Volume (Direct Countries)
Primary DI / UDI-DI
07640187920451
Basic UDI-DI
764018792IDCLHAEK
EMDN Code
P900402 Resorbable filling and reconstruction devices
Device Class
Class III
Medical Purpose
INTRADERMAL CROSS-LINKED HA

Manufacturer details

EUDAMED SRN
CH-PR-000059255

Other devices from Rose Pharma S.A.

See all devices from Rose Pharma S.A. →

Properties

  • Sterile